内镜经鼻入路治疗库欣病:162例多中心回顾性研究及术后早期皮质醇评估
这项多中心回顾性队列研究纳入162例生化确诊的库欣病患者,均接受内镜经鼻入路垂体腺瘤切除术,评估术后早期晨皮质醇水平与长期复发的关系。结果显示术后前3天晨皮质醇<5 µg/dL与复发风险降低显著相关,术后第1天皮质醇<2 µg/dL者无复发生存率达91.8%,平均随访29.8±28.7个月。
要点
- 术后前3天晨皮质醇<5 µg/dL是长期缓解的强预测因子。
- 术后第1天皮质醇<2 µg/dL与复发风险显著降低相关。
- 两个切点比较,较高皮质醇水平者复发风险有升高趋势但未达统计学显著。
核心结论
- 术后早期皮质醇<5 µg/dL是库欣病长期缓解的强预测因子。
- 术后第1天皮质醇<2 µg/dL亦与复发风险降低显著相关。
研究设计与样本
- 多中心观察性回顾性队列研究,纳入162例生化确诊的库欣病患者,2007年1月至2021年9月接受内镜经鼻入路切除术。
- 参与机构为美国南加州大学、意大利那不勒斯费德里科二世大学和奥地利维也纳医科大学。
主要发现
- 术后前3天晨皮质醇<2 µg/dL与复发风险降低相关(OR 0.08,95%CI 0.004-0.38,p=0.01)。
- 术后前3天晨皮质醇<5 µg/dL与复发风险降低相关(OR 0.25,95%CI 0.09-0.61,p=0.003)。
- 两个切点比较,较高皮质醇水平者复发风险有升高趋势但无统计学意义(OR 2.1,95%CI 0.59-7.81,p=0.25)。
- 术后第1天皮质醇<2 µg/dL者无复发生存率为91.8%,平均随访29.8±28.7个月。
关键数值与推荐
- 术后前3天晨皮质醇<2 µg/dL或<5 µg/dL与较低复发风险相关。
- 术后第1天皮质醇<2 µg/dL对应91.8%无复发生存率。
临床怎么用
- 术后前3天监测晨皮质醇有助于预测库欣病长期缓解。
- 术后第1天皮质醇<2 µg/dL提示复发风险低,可辅助制定随访策略。
局限性
- 本研究为回顾性观察性设计,可能存在选择偏倚。
- 两个皮质醇切点比较的差异未达统计学显著,需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cushing's disease (CD) is a severe endocrine disorder that remains difficult to treat. The first-line treatment for confirmed CD is selective pituitary adenoma resection. Postoperative hormonal remission may not be achieved, though, despite surgical intervention. Effective postoperative monitoring of the hormonal response in CD remains challenging. METHODS: A multicenter observational retrospective cohort study was conducted including 162 patients with CD who underwent endoscopic endonasal resection from January 2007 to September 2021. Three institutions from the United States and Europe participated: University of Southern California, University of Naples Federico II, and Medical University of Vienna. Clinical information including age, sex, preoperative serum and urinary free cortisol levels, imaging findings, histopathological examination including immunohistochemical results, postoperative endocrinological results, and time to follow-up were reported. RESULTS: Data were reviewed for 162 patients with biochemically confirmed CD undergoing surgery via an endoscopic endonasal approach. Morning cortisol < 2 µg/dL or < 5 µg/dL during the first 3 postoperative days (PODs) was associated with lower odds of recurrence (for < 2 µg/dL: OR 0.08, 95% CI 0.004-0.38 [p = 0.01]; for < 5 µg/dL: OR 0.25, 95% CI 0.09-0.61 [p = 0.003]). However, when comparing the two cutoff values (< 2 µg/dL and < 5 µg/dL), a trend toward increased risk was observed in patients with higher cortisol levels, although the difference was not statistically significant (OR 2.1, 95% CI 0.59-7.81; p = 0.25). CONCLUSIONS: Early postoperative hypocortisolemia with cortisol levels < 5 µg/dL within the first 3 days after surgery is a strong predictor of long-term remission. A cortisol level < 2 µg/dL on POD 1 was also significantly associated with a lower risk of recurrence, corresponding to a 91.8% recurrence-free survival rate with a mean follow-up of 29.8 ± 28.7 months.
引用
- Bove I, Berardinelli J, Briggs RG, et al. Endoscopic endonasal approach for adrenocorticotropic hormone-producing pituitary neuroendocrine tumor causing Cushing's disease: multicenter retrospective study on 162 patients with early postoperative cortisol assessment. J Neurosurg. 2026. PMID: 42600179. doi:10.3171/2026.3.JNS252724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。